Piritrexim

Drug Profile

Piritrexim

Alternative Names: BW 301U; Piritrexim isethionate

Latest Information Update: 25 Mar 2003

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ILEX Oncology Inc
  • Class Pyrimidines; Small molecules
  • Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Kaposi's sarcoma; Pain
  • Discontinued Bladder cancer

Most Recent Events

  • 25 Mar 2003 A study has been added to the Cancer therapeutic trials section
  • 13 Nov 1998 Discontinued-II for Bladder cancer in European Union (PO)
  • 13 Nov 1998 Discontinued-II for Bladder cancer in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top